Ngā hua rapu - David Hilton‐Jones

Whakamahine hua
  1. 1
    International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009

    International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009 mā Olivier Benvéniste, David Hilton‐Jones

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    The myotonic dystrophies: diagnosis and management

    The myotonic dystrophies: diagnosis and management mā C Turner, David Hilton‐Jones

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Diagnostic criteria for inclusion body myositis

    Diagnostic criteria for inclusion body myositis mā David Hilton‐Jones, Stefen Brady

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Spontaneous intracranial hypotension.

    Spontaneous intracranial hypotension. mā Shelley Renowden, Ralph Gregory, N. Hyman, David Hilton‐Jones

    I whakaputaina 1995
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Motor neuron disease in England and Wales, 1959-1979.

    Motor neuron disease in England and Wales, 1959-1979. mā Jonathan Buckley, C Warlow, Peter G. Smith, David Hilton‐Jones, S Irvine, John Tew

    I whakaputaina 1983
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations

    Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations mā Homa Tajsharghi, David Hilton‐Jones, Olayinka Raheem, Anna Maija Saukkonen, Anders Oldfors, Bjarne Udd

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis

    A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis mā Stefen Brady, Waney Squier, C. Sewry, Michael G. Hanna, David Hilton‐Jones, Janice L. Holton

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Myasthenia gravis: Association of British Neurologists’ management guidelines

    Myasthenia gravis: Association of British Neurologists’ management guidelines mā Jon Sussman, Maria Elena Farrugia, Paul Maddison, Marguerite Hill, Maria Isabel Leite, David Hilton‐Jones

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken

    Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken mā Olivier Benvéniste, Werner Stenzel, David Hilton‐Jones, Marco Sandri, Olivier Boyer, Baziel G.M. van Engelen

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues.

    Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues. mā Paul M. Matthews, Julian M. Hopkin, R. M. Brown, J Stephenson, David Hilton‐Jones, Garry K. Brown

    I whakaputaina 1994
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome

    The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome mā Peter J. Maddison, J. McConville, Maria Elena Farrugia, Nigel P. Davies, Michael R. Rose, F. Norwood, Heinz Jungbluth, S. Robb, David Hilton‐Jones

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    The need for biochemical testing in beta‐enolase deficiency in the genomic era

    The need for biochemical testing in beta‐enolase deficiency in the genomic era mā Ralph Wigley, R. Scalco, A. Gardiner, Richard Godfrey, Suzanne Booth, Richard Kirk, David Hilton‐Jones, Henry Houlden, Simon Heales, Rosaline C. M. Quinlivan

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Guidelines for treatment of autoimmune neuromuscular transmission disorders

    Guidelines for treatment of autoimmune neuromuscular transmission disorders mā Geir Skeie, Slobodan Apostolski, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Lutz Harms, David Hilton‐Jones, Arthur Melms, Jan J.G.M. Verschuuren, H. W. Horge

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Long-term observational study of sporadic inclusion body myositis

    Long-term observational study of sporadic inclusion body myositis mā Olivier Benvéniste, Marguerite Guiguet, John Freebody, O. Dubourg, Waney Squier, Thierry Maisonobe, Tanya Stojkovic, Maria Isabel Leite, Yves Allenbach, S. Herson, Stefen Brady, B. Eymard, David Hilton‐Jones

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Guidelines for the treatment of autoimmune neuromuscular transmission disorders

    Guidelines for the treatment of autoimmune neuromuscular transmission disorders mā Geir Skeie, Slobodan Apostolski, Amelia Evoli, Nils Erik Gilhus, I. K. Hart, Lutz Harms, David Hilton‐Jones, Arthur Melms, Jan J.G.M. Verschuuren, H. W. Horge

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis

    Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis mā Pedro M. Rodríguez Cruz, Michal Al-Hajjar, Saif Huda, Leslie Jacobson, Mark Woodhall, Sandeep Jayawant, Camilla Buckley, David Hilton‐Jones, David Beeson, Angela Vincent, Maria Isabel Leite, Jacqueline Palace

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG

    IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG mā Saif Huda, Patrick Waters, Mark Woodhall, Maria Isabel Leite, Leslie Jacobson, Anna De Rosa, Michelangelo Maestri, Roberta Ricciardi, Jeannine M. Heckmann, Angelina Maniaol, Amelia Evoli, Judy Cossins, David Hilton‐Jones, Angela Vincent

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland

    Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland mā Boglárka Bánsági, Thalia Antoniadi, Sarah Burton‐Jones, Sinéad M. Murphy, John C. McHugh, Michael Alexander, Richard A. Wells, Joanna P. Davies, David Hilton‐Jones, Hanns Lochmüller, Patrick F. Chinnery, Rita Horváth

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy

    Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy mā Germán Morís, Libby Wood, Roberto Fernández‐Torrón, José Andrés González Coraspe, Chris Turner, David Hilton‐Jones, Fiona Norwood, Tracey Willis, Matt Parton, Mark Rogers, Simon Hammans, Mark Roberts, Elizabeth Househam, Maggie Williams, Hanns Lochmüller, Teresinha Evangelista

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA

    Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA mā Mark Price, Victoria Barghout, Olivier Benvéniste, Lisa Christopher‐Stine, Alastair Corbett, Marjolein Visser, David Hilton‐Jones, John T. Kissel, Thomas E. Lloyd, Ingrid E. Lundberg, Francis Mastaglia, Tahseen Mozaffar, Merrilee Needham, Jens Schmidt, Kumaraswamy Sivakumar, Carla DeMuro, Brian S. Tseng

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: